Tina Phe, | |
4423 Shadowdale Dr, Houston, TX 77041-8718 | |
(713) 466-6872 | |
(713) 466-9547 |
Full Name | Tina Phe |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 4423 Shadowdale Dr, Houston, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003369026 | NPI | - | NPPES |
111839 | Other | TX | PROFESSIONAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 111839 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tina Phe, 4423 Shadowdale Dr, Houston, TX 77041-8718 Ph: (713) 466-6872 | Tina Phe, 4423 Shadowdale Dr, Houston, TX 77041-8718 Ph: (713) 466-6872 |
News Archive
A sharp decline in breast cancer incidence rates among non-Hispanic white women in the U.S. after a dramatic drop in the use of postmenopausal hormone therapy did not continue through 2007, according to a new study from the American Cancer Society and the National Cancer Institute.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the preclinical activity of Arno's drug candidate AR-42 against leukemia stem cells (LSCs).
Doctors have long characterized epilepsy as a brain disorder, but researchers at Case Western Reserve University have found that part of the autonomic nervous system functions differently in epilepsy during the absence of seizures.This connection to the involuntary division of the nervous system may have implications for diagnosing and treating the disease and understanding sudden unexpected death in epilepsy
By 2012's end, health care providers across Texas will have submitted proposals to state leaders to transform the way they care for the poor and uninsured. They have been spurred by a Medicaid waiver Texas officials sought and received in 2011 from the federal government, one that ties financing to cooperation, cost efficiency and better patient outcomes.
Advanced medical technology and analysis methods now being promoted through the Food and Drug Administration's Critical Path Initiative to facilitate the development of drugs, biologics and devices can help address differences between women and men in the detection and treatment of disease, according to a paper published in the Winter 2007 issue of Drug Discovery Today: Technologies.
› Verified 8 days ago
Mr. Michael T Mccormack, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9900 Westpark Dr, Suite 100, Houston, TX 77063 Phone: 713-528-3030 Fax: 713-528-0442 | |
Jency Mignon Mcclain, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5757 Woodway Dr, Suite 125, Houston, TX 77057 Phone: 713-787-5015 Fax: 713-787-5032 | |
Melody Costello, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17419 Saxon Dr, Houston, TX 77095 Phone: 936-250-1167 | |
Molly Schubert, M.S. CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1240 Blalock Rd Ste 170, Houston, TX 77055 Phone: 713-468-0300 Fax: 713-468-0336 | |
Mrs. Chelsie Nicole Luhn, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3000 Richmond Ave Ste 240, Houston, TX 77098 Phone: 281-823-9191 | |
Solange Inzillo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9757 Pine Lake Drive, #4025, Houston, TX 77055 Phone: 713-574-8613 |